Nvidia Soars to New All-Time High: 3 ASX ETFs Set to Benefit from Approval to Sell Advanced Chips to China

Tuesday, Jul 15, 2025 9:05 pm ET1min read

Nvidia shares have reached an all-time high of $172.40, nearly doubling since April. The chip maker faced challenges including restrictions on selling its H20 chips to China, but has now received approval to do so again. Several ASX ETFs, including the Global X Fang+ ETF, Betashares Nasdaq 100 ETF, and iShares S&P 500 AUD ETF, have high allocations to Nvidia and could benefit from this development.

Nvidia Corp. (NASDAQ: NVDA) shares reached an all-time high of $172.40 on July 1, 2025, nearly doubling from its April low of $86.63 [4]. This remarkable turnaround comes after the company faced several challenges, including restrictions on selling its advanced H20 computer chips to China. However, Nvidia has now received approval to resume these sales, signaling a significant boost for the tech giant and its investors.

In April, Nvidia faced a 20% drop in its share price due to the arrival of Chinese start-up AI company Deepseek, followed by US President Donald Trump's tariffs and the subsequent ban on selling its H20 chips to China [4]. The company wrote off $5.5 billion in inventory due to these restrictions [4]. However, a meeting between Nvidia CEO Jensen Huang and President Trump led to a reversal of the US policy, allowing Nvidia to resume its H20 chip sales to China [4].

Nvidia's approval to sell its advanced chips to China marks a crucial step forward for the company. The H20 GPU is designed for industrial applications in China, and its reintroduction to the market signifies Nvidia's commitment to conducting business within the rules set by the US and Chinese governments [2]. This move is expected to benefit Nvidia's business in the region, given the high demand for advanced AI and graphics processing units in China [2].

Several ASX ETFs, including the Global X Fang+ ETF, Betashares Nasdaq 100 ETF, and iShares S&P 500 AUD ETF, have high allocations to Nvidia and could benefit from this development. These ETFs provide diversified exposure to top stocks, including tech giants, and allow investors to build a portfolio without needing to be an expert stock picker [3].

Investors should closely monitor Nvidia's performance and the broader market trends to capitalize on this opportunity. The approval to resume H20 chip sales to China is a positive sign for the company and its investors, but it is essential to remain cautious and consider the overall market conditions.

References:
[1] https://www.benzinga.com/markets/large-cap/25/07/46377891/wall-street-hits-record-highs-as-nvidia-tops-4-trillion-trump-ramps-up-trade-tensions-this-week-in-markets
[2] https://www.fxleaders.com/news/2025/07/15/nvidia-u-s-clears-nvidia-to-resume-h20-gpu-sales-to-china/
[3] https://www.ainvest.com/news/3-beginner-friendly-asx-etfs-diversified-portfolio-2507/
[4] https://www.fool.com.au/2025/07/16/nvidia-soars-on-game-changing-news-3-asx-etfs-set-to-benefit/

Nvidia Soars to New All-Time High: 3 ASX ETFs Set to Benefit from Approval to Sell Advanced Chips to China

Comments



Add a public comment...
No comments

No comments yet